Although high ITPKC expression was not associated with immune function nor with any immune cell fraction, low ITPKC triple negative breast cancer was significantly associated with activated cell proliferation, and they achieved a significantly rate in pathological complete response (disappearance of tumor) after neoadjuvant chemotherapy. This evidence concerns the gene ITPKC and triple-negative breast carcinoma.